Evolve Global Financials
| LIFE-U Etf | USD 19.89 0.01 0.05% |
Net Expense Ratio 0.0045 |
Evolve |
The data published in Evolve Global's official financial statements typically reflect Evolve Global's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Evolve Global's quantitative information. For example, before you start analyzing numbers published by Evolve accountants, it's essential to understand Evolve Global's liquidity, profitability, and earnings quality within the context of the Evolve Funds Group Inc space in which it operates.
Please note, the presentation of Evolve Global's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Evolve Global's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Evolve Global's management manipulating its earnings.
Evolve Global Etf Summary
Evolve Global competes with First Asset, First Asset, Harvest Equal, CI Canada, and Global Dividend. EVOLVE GLBL is traded on Toronto Stock Exchange in Canada.| Instrument | Canada Etf |
| Exchange | Toronto Exchange |
| ISIN | CA30051T3091 |
| Region | Others |
| Investment Issuer | Others |
| Etf Family | Evolve Funds Group Inc |
| Benchmark | Dow Jones Industrial |
| Phone | NA |
| Currency | USD - US Dollar |
You should never invest in Evolve Global without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Evolve Etf, because this is throwing your money away. Analyzing the key information contained in Evolve Global's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Evolve Global Key Financial Ratios
Evolve Global's financial ratios allow both analysts and investors to convert raw data from Evolve Global's financial statements into concise, actionable information that can be used to evaluate the performance of Evolve Global over time and compare it to other companies across industries.Evolve Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Evolve Global's current stock value. Our valuation model uses many indicators to compare Evolve Global value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Evolve Global competition to find correlations between indicators driving Evolve Global's intrinsic value. More Info.Evolve Global Healthcare is rated fifth overall ETF in beta as compared to similar ETFs. It also is rated fifth overall ETF in one year return as compared to similar ETFs . Comparative valuation analysis is a catch-all model that can be used if you cannot value Evolve Global by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Evolve Global's Etf. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Evolve Global Healthcare Systematic Risk
Evolve Global's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Evolve Global volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Evolve Global Healthcare correlated with the market. If Beta is less than 0 Evolve Global generally moves in the opposite direction as compared to the market. If Evolve Global Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Evolve Global Healthcare is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Evolve Global is generally in the same direction as the market. If Beta > 1 Evolve Global moves generally in the same direction as, but more than the movement of the benchmark.
Evolve Global December 4, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Evolve Global help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Evolve Global Healthcare. We use our internally-developed statistical techniques to arrive at the intrinsic value of Evolve Global Healthcare based on widely used predictive technical indicators. In general, we focus on analyzing Evolve Etf price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Evolve Global's daily price indicators and compare them against related drivers.
| Information Ratio | (0.46) | |||
| Maximum Drawdown | 4.03 | |||
| Value At Risk | (1.53) | |||
| Potential Upside | 0.1511 |
Other Information on Investing in Evolve Etf
Evolve Global financial ratios help investors to determine whether Evolve Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Evolve with respect to the benefits of owning Evolve Global security.